Oncology approvals are on an upward trend Interviewee/Contributor Bruno Pagliara Organisation MedNous Cancer (Oncology) Read more about Oncology approvals are on an upward trend
Finding a link between the microbiome and disease Interviewee/Contributor Steff Taelman Organisation BioLizard NV Drug discovery Read more about Finding a link between the microbiome and disease
Enterome starts development of new cancer drugs Interviewee/Contributor Jan Fagerberg Organisation Enterome SA Therapeutic cancer vaccines Read more about Enterome starts development of new cancer drugs
Mimicking anti-viral innate immunity against cancer Interviewee/Contributor Alex Karlsson-Parra and Sijme Zeilemaker Organisation Immunicum AB Therapeutic cancer vaccines Read more about Mimicking anti-viral innate immunity against cancer
Christmas comes early for Europe's biotech stocks Interviewee/Contributor William Ellington Organisation MedNous Stock market performance Read more about Christmas comes early for Europe's biotech stocks
Integrated product development for ATMPs Interviewee/Contributor Claes Buxfeldt and Paula Salmikangas Organisation NDA Advisory Services Ltd Gene therapy Heath Technology Assessment (HTA) Policy & Regulation Regenerative medicine (Stem cells) Read more about Integrated product development for ATMPs
The role of oncolytic viruses in immuno-oncology Interviewee/Contributor Bernard Huber and Paul Higham Organisation Oryx GmbH & Co KG and Valo Therapeutics Ltd Drug discovery Strategy Oncolytic viruses Read more about The role of oncolytic viruses in immuno-oncology
J&J plans large Covid-19 vaccine trial Interviewee/Contributor Peter Charlish Organisation MedNous Vaccine Read more about J&J plans large Covid-19 vaccine trial
Investors support new antifungal agent Interviewee/Contributor Ralf Schmid and Emma Harvey Organisation F2G Ltd Drug discovery Finance Venture Capital Read more about Investors support new antifungal agent
Covid-19: still more questions than answers Interviewee/Contributor Peter Charlish Organisation MedNous Clinical trials Vaccine Read more about Covid-19: still more questions than answers